Newgenivf Group Limited Stock Analysis

NewGenIvf Stock Analysis Notes

The company has price-to-book ratio of 0.03. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NewGenIvf Group recorded earning per share (EPS) of 4195.34. The entity had not issued any dividends in recent years. The firm had 1:3 split on the 26th of January 2026. To find out more about NewGenIvf Group Limited contact the company at 66 2 116 9641 or learn more at https://newgenivf.com.

NewGenIvf Group Investment Alerts

NewGenIvf Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 826.48 K.

NewGenIvf Profitablity

The company has Profit Margin (PM) of 3.81 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is normal as compared to the sector avarege. Similarly, it shows Operating Margin (OM) of (1.96) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.96.

Management Efficiency

NewGenIvf Group has return on total asset (ROA) of (0.231) % which means that it has lost $0.231 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 1.6054 %, meaning that it created $1.6054 on every $100 dollars invested by stockholders. NewGenIvf Group's management efficiency ratios could be used to measure how well NewGenIvf Group manages its routine affairs as well as how well it operates its assets and liabilities. The NewGenIvf Group's current Return On Equity is estimated to increase to 0.47, while Return On Tangible Assets are forecasted to increase to (0.16). At this time, NewGenIvf Group's Other Current Assets are most likely to increase significantly in the upcoming years. The NewGenIvf Group's current Debt To Assets is estimated to increase to 0.80, while Non Current Assets Total are projected to decrease to roughly 520.7 K.

Technical Drivers

As of the 21st of February, NewGenIvf Group secures the Mean Deviation of 7.49, standard deviation of 10.53, and Risk Adjusted Performance of (0.15). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NewGenIvf Group, as well as the relationship between them. Please verify NewGenIvf Group market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and skewness to decide if NewGenIvf Group Limited is priced some-what accurately, providing market reflects its recent price of 0.86 per share. Given that NewGenIvf Group is a hitting penny stock territory we strongly suggest to closely look at its jensen alpha.

NewGenIvf Group Price Movement Analysis

NewGenIvf Group Outstanding Bonds

NewGenIvf Group Predictive Daily Indicators

NewGenIvf Group Forecast Models

NewGenIvf Group's time-series forecasting models are one of many NewGenIvf Group's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NewGenIvf Group's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

NewGenIvf Group Bond Ratings

NewGenIvf Group Limited financial ratings play a critical role in determining how much NewGenIvf Group have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for NewGenIvf Group's borrowing costs.

NewGenIvf Group Total Assets Over Time

NewGenIvf Group Assets Financed by Debt

The debt-to-assets ratio shows the degree to which NewGenIvf Group uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

NewGenIvf Group Debt Ratio

80.0

It seems as most of the NewGenIvf Group's assets are financed through debt. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the NewGenIvf Group's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of NewGenIvf Group, which in turn will lower the firm's financial flexibility.

NewGenIvf Group Corporate Bonds Issued

NewGenIvf Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how NewGenIvf Group prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NewGenIvf shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as NewGenIvf Group. By using and applying NewGenIvf Stock analysis, traders can create a robust methodology for identifying NewGenIvf entry and exit points for their positions.

When running NewGenIvf Group's price analysis, check to measure NewGenIvf Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NewGenIvf Group is operating at the current time. Most of NewGenIvf Group's value examination focuses on studying past and present price action to predict the probability of NewGenIvf Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NewGenIvf Group's price. Additionally, you may evaluate how the addition of NewGenIvf Group to your portfolios can decrease your overall portfolio volatility.